LEP and type 2 diabetes mellitus: As several animal studies using streptozotocin-induced rat and ob/ob (leptin-deficient) mouse models of diabetes have shown insulinotropic actions of GIP and/or GIP receptor agonists [65–67], these models of type 2 diabetes may not be suitable to study the phenomenon of reduced insulinotropic activity of GIP in human type 2 diabetes.